Invivyd (IVVD) grants 32,876 stock options to director Bolno

Rhea-AI Filing Summary

Invivyd, Inc. reported that director Paul Bolno received a grant of stock options covering 32,876 shares of common stock. The options have an exercise price of $1.04 per share and expire on May 18, 2036. The grant vests in full on the earlier of May 19, 2027 or the date of Invivyd's 2027 Annual Meeting of Stockholders, provided he continues in service through that vesting date. After this grant, Bolno holds options for 32,876 underlying shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BOLNO PAUL

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	32,876	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 32,876 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options Granted: 32,876 options Exercise Price: $1.04 per share Underlying Shares: 32,876 shares +3 more

6 metrics

Options Granted 32,876 options Stock Option (Right to Buy) granted to director Paul Bolno

Exercise Price $1.04 per share Conversion/exercise price of the stock options

Underlying Shares 32,876 shares Common stock underlying the option award

Expiration Date May 18, 2036 Option term end date

Vesting Date Earlier of May 19, 2027 or 2027 meeting Full vesting contingent on continuous service

Post-transaction Options Held 32,876 options Total options held by Bolno following this grant

Key Terms

Stock Option (Right to Buy), exercise price, vests in full, Annual Meeting of Stockholders, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 1.0400 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests in full financial

"This option was granted on May 19, 2026 and vests in full upon the earlier of"

Annual Meeting of Stockholders financial

"the date of the Issuer's 2027 Annual Meeting of Stockholders"

continuous service financial

"subject to the Reporting Person's continuous service through such vesting date"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOLNO PAUL

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CONNECTICUT 06510

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.04	05/19/2026		A		32,876		(1)	05/18/2036	Common Stock	32,876	$0	32,876	D

Explanation of Responses:

1. This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

	/s/ Jill Andersen attorney-in-fact for Paul Bolno	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Invivyd (IVVD) disclose for Paul Bolno?

Invivyd disclosed that director Paul Bolno received a grant of 32,876 stock options. These options give him the right to buy 32,876 Invivyd common shares at a fixed exercise price, subject to vesting conditions and an expiration date in 2036.

What are the key terms of Paul Bolno’s Invivyd stock option grant?

The grant covers 32,876 options with a $1.04 exercise price per share. The options expire on May 18, 2036 and vest in full on the earlier of May 19, 2027 or Invivyd’s 2027 Annual Meeting, assuming continuous service.

When do Paul Bolno’s Invivyd stock options vest?

The options vest in full on the earlier of May 19, 2027 or the date of Invivyd’s 2027 Annual Meeting of Stockholders. Vesting is conditioned on Bolno maintaining continuous service with the company through the applicable vesting date.

How many Invivyd shares underlie Paul Bolno’s new stock options?

The option grant is linked to 32,876 underlying shares of Invivyd common stock. Once the options vest and if exercised at $1.04 per share, Bolno could acquire up to 32,876 Invivyd shares from this award alone.

Is Paul Bolno’s Invivyd stock option grant an open-market purchase?

No, the transaction is a grant of stock options classified as an acquisition award, not an open-market share purchase. The options were granted at no cost per option but carry a $1.04 per-share exercise price if later exercised.